A trailblazing Latin American leader in Alzheimer’s disease research and a compassionate patient advocate
Enjoying our latest content?
Log in or create an account to continue
- Access the most recent journalism from Nature's award-winning team
- Explore the latest features & opinion covering groundbreaking research
or
References
Acosta-Baena, N. et al. Lancet Neurol. 10, 213–220 (2011).
Reiman, E. M. et al. Lancet Neurol. 11, 1048–1056 (2012).
Arboleda-Velasquez, J. F. et al. Nat. Med. 25, 1680–1683 (2019).
Quiroz, Y. T. et al. N. Engl. J. Med. 390, 2156–2164 (2024).
Lopera, F. et al. Nat. Med. 29, 1243–1252 (2023).
Acknowledgements
A.I. is supported by grants from ReDLat (National Institutes of Health and the Fogarty International Center (FIC), National Institutes of Aging (R01 AG057234, R01 AG075775, R01 AG21051, R01 AG083799, CARDS-NIH), Alzheimer’s Association (SG-20-725707), Rainwater Charitable Foundation – The Bluefield project to cure FTD, and Global Brain Health Institute)), ANID/FONDECYT Regular (1210195, 1210176 and 1220995); and ANID/FONDAP/15150012. The contents of this publication are solely the author’s responsibility and do not represent the official views of these institutions.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Ibáñez, A., Bateman, R. & Santamaria-García, H. Francisco Lopera (1951–2024). Nat Aging 4, 1516–1517 (2024). https://doi.org/10.1038/s43587-024-00735-8
Published:
Version of record:
Issue date:
DOI: https://doi.org/10.1038/s43587-024-00735-8
